Literature DB >> 25111715

Fetal phenotype associated with the 22q11 deletion.

Anne-Claire Noël1, Fanny Pelluard, Anne-Lise Delezoide, Louise Devisme, Laurence Loeuillet, Brigitte Leroy, Alain Martin, Raymonde Bouvier, Annie Laquerriere, Corinne Jeanne-Pasquier, Betty Bessieres-Grattagliano, Charlotte Mechler, Elisabeth Alanio, Camille Leroy, Dominique Gaillard.   

Abstract

The 22q11 deletion syndrome is one of the most common human microdeletion syndromes, with a wide spectrum of abnormalities. The fetal phenotype associated with the 22q11 deletion is poorly described in the literature. A national retrospective study was performed from 74 feto-pathological examinations. The objectives were to evaluate the circumstances of the 22q11 deletion diagnosis and to describe fetal anomalies. Post mortem examinations were performed after 66 terminations of pregnancy and eight fetal deaths. The series included nine fetuses from the first trimester, 55 from the second trimester, and ten from the third trimester. A 22q11 FISH analysis was recommended for 57 fetuses after multidisciplinary prenatal diagnostic counseling and for 17 fetuses by a fetal pathologist. Conotruncal heart defects were the most common anomalies (65 fetuses), followed by thymus defects (62 fetuses), and malformations of the urinary tract (25 fetuses). This study identified several unusual and severe features rarely described in the literature. Neurological abnormalities were described in ten fetuses, with seven neural tube defects and five arhinencephalies. This series also included lethal malformations: two hypoplastic left heart syndromes, two bilateral renal agenesis, and one tracheal agenesis. Genetic analysis for a 22q11 deletion is usually indicated when a congenital conotruncal heart and/or thymus defect is detected, but might also be useful in case of other lethal or severe malformations that initially led to the termination of pregnancy.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  22q11 deletion syndrome; DiGeorge syndrome; conotruncal cardiac defect; fetus; holoprosencephaly; kidney; neural tube defect; prenatal diagnosis; thymus; upper respiratory tract

Mesh:

Year:  2014        PMID: 25111715     DOI: 10.1002/ajmg.a.36720

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  14 in total

Review 1.  Etiology and management of early pregnancy renal anhydramnios: Is there a place for serial amnioinfusions?

Authors:  Angie C Jelin; Katelynn G Sagaser; Katherine R Forster; Tochi Ibekwe; Mary E Norton; Eric B Jelin
Journal:  Prenat Diagn       Date:  2020-02-19       Impact factor: 3.050

2.  Expanding the fetal phenotype: Prenatal sonographic findings and perinatal outcomes in a cohort of patients with a confirmed 22q11.2 deletion syndrome.

Authors:  Erica Schindewolf; Nahla Khalek; Mark P Johnson; Juliana Gebb; Beverly Coleman; Terrence Blaine Crowley; Elaine H Zackai; Donna M McDonald-McGinn; Julie S Moldenhauer
Journal:  Am J Med Genet A       Date:  2018-07-28       Impact factor: 2.802

Review 3.  Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development.

Authors:  Daniel W Meechan; Thomas M Maynard; Eric S Tucker; Alejandra Fernandez; Beverly A Karpinski; Lawrence A Rothblat; Anthony-S LaMantia
Journal:  Prog Neurobiol       Date:  2015-04-09       Impact factor: 11.685

Review 4.  Congenital heart diseases and cardiovascular abnormalities in 22q11.2 deletion syndrome: From well-established knowledge to new frontiers.

Authors:  Marta Unolt; Paolo Versacci; Silvia Anaclerio; Caterina Lambiase; Giulio Calcagni; Matteo Trezzi; Adriano Carotti; Terrence Blaine Crowley; Elaine H Zackai; Elizabeth Goldmuntz; James William Gaynor; Maria Cristina Digilio; Donna M McDonald-McGinn; Bruno Marino
Journal:  Am J Med Genet A       Date:  2018-04-16       Impact factor: 2.802

5.  Genetic Drivers of Kidney Defects in the DiGeorge Syndrome.

Authors:  Esther Lopez-Rivera; Yangfan P Liu; Miguel Verbitsky; Blair R Anderson; Valentina P Capone; Edgar A Otto; Zhonghai Yan; Adele Mitrotti; Jeremiah Martino; Nicholas J Steers; David A Fasel; Katarina Vukojevic; Rong Deng; Silvia E Racedo; Qingxue Liu; Max Werth; Rik Westland; Asaf Vivante; Gabriel S Makar; Monica Bodria; Matthew G Sampson; Christopher E Gillies; Virginia Vega-Warner; Mariarosa Maiorana; Donald S Petrey; Barry Honig; Vladimir J Lozanovski; Rémi Salomon; Laurence Heidet; Wassila Carpentier; Dominique Gaillard; Alba Carrea; Loreto Gesualdo; Daniele Cusi; Claudia Izzi; Francesco Scolari; Joanna A E van Wijk; Adela Arapovic; Mirna Saraga-Babic; Marijan Saraga; Nenad Kunac; Ali Samii; Donna M McDonald-McGinn; Terrence B Crowley; Elaine H Zackai; Dorota Drozdz; Monika Miklaszewska; Marcin Tkaczyk; Przemyslaw Sikora; Maria Szczepanska; Malgorzata Mizerska-Wasiak; Grazyna Krzemien; Agnieszka Szmigielska; Marcin Zaniew; John M Darlow; Prem Puri; David Barton; Emilio Casolari; Susan L Furth; Bradley A Warady; Zoran Gucev; Hakon Hakonarson; Hana Flogelova; Velibor Tasic; Anna Latos-Bielenska; Anna Materna-Kiryluk; Landino Allegri; Craig S Wong; Iain A Drummond; Vivette D'Agati; Akira Imamoto; Jonathan M Barasch; Friedhelm Hildebrandt; Krzysztof Kiryluk; Richard P Lifton; Bernice E Morrow; Cecile Jeanpierre; Virginia E Papaioannou; Gian Marco Ghiggeri; Ali G Gharavi; Nicholas Katsanis; Simone Sanna-Cherchi
Journal:  N Engl J Med       Date:  2017-01-25       Impact factor: 91.245

6.  Neuropsychiatric aspects of 22q11.2 deletion syndrome: considerations in the prenatal setting.

Authors:  Anne S Bassett; Gregory Costain; Christian R Marshall
Journal:  Prenat Diagn       Date:  2016-11-14       Impact factor: 3.050

7.  Prenatal sonographic and cytogenetic/molecular findings of 22q11.2 microdeletion syndrome in 48 confirmed cases in a single tertiary center.

Authors:  Tugba Sarac Sivrikoz; Seher Basaran; Recep Has; Birsen Karaman; Ibrahim Halil Kalelioglu; Melike Kirgiz; Umut Altunoglu; Atil Yuksel
Journal:  Arch Gynecol Obstet       Date:  2021-06-18       Impact factor: 2.344

8.  MLPA analysis of 32 foetuses with a congenital heart defect and 1 foetus with renal defects - pilot study. The significant frequency rate of presented pathological CNV.

Authors:  Andrea Stefekova; Pavlina Capkova; Zuzana Capkova; Vaclava Curtisova; Josef Srovnal; Enkhjargalan Mracka; Eva Klaskova; Martin Prochazka
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-03-31       Impact factor: 1.245

Review 9.  Dissecting the complexity of CNV pathogenicity: insights from Drosophila and zebrafish models.

Authors:  Tanzeen Yusuff; Georgios Kellaris; Santhosh Girirajan; Nicholas Katsanis
Journal:  Curr Opin Genet Dev       Date:  2021-03-31       Impact factor: 4.665

Review 10.  22q11 deletion syndrome: current perspective.

Authors:  Bülent Hacıhamdioğlu; Duygu Hacıhamdioğlu; Kenan Delil
Journal:  Appl Clin Genet       Date:  2015-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.